Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1962 1
1963 1
1964 2
1965 4
1966 3
1967 8
1968 4
1969 3
1970 7
1971 1
1973 1
1975 1
1976 3
1977 9
1978 17
1979 12
1980 14
1981 15
1982 16
1983 18
1984 20
1985 28
1986 22
1987 42
1988 27
1989 32
1990 54
1991 51
1992 36
1993 32
1994 46
1995 38
1996 34
1997 66
1998 67
1999 78
2000 64
2001 81
2002 95
2003 80
2004 81
2005 100
2006 105
2007 101
2008 102
2009 101
2010 108
2011 115
2012 126
2013 125
2014 137
2015 136
2016 147
2017 161
2018 142
2019 164
2020 174
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

3,026 results
Results by year
Filters applied: . Clear all
Page 1
Telomerase-Targeted Cancer Immunotherapy.
Mizukoshi E, Kaneko S. Mizukoshi E, et al. Among authors: kaneko s. Int J Mol Sci. 2019 Apr 12;20(8):1823. doi: 10.3390/ijms20081823. Int J Mol Sci. 2019. PMID: 31013796 Free PMC article. Review.
Evidence-based clinical practice guideline for adult Still's disease.
Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T. Mimura T, et al. Among authors: kaneko s. Mod Rheumatol. 2018 Sep;28(5):736-757. doi: 10.1080/14397595.2018.1465633. Epub 2018 May 9. Mod Rheumatol. 2018. PMID: 29651907 Review.
Immune cell therapy for hepatocellular carcinoma.
Mizukoshi E, Kaneko S. Mizukoshi E, et al. Among authors: kaneko s. J Hematol Oncol. 2019 May 29;12(1):52. doi: 10.1186/s13045-019-0742-5. J Hematol Oncol. 2019. PMID: 31142330 Free PMC article. Review.
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A. Xu H, et al. Among authors: kaneko s. Cell Stem Cell. 2019 Apr 4;24(4):566-578.e7. doi: 10.1016/j.stem.2019.02.005. Epub 2019 Mar 7. Cell Stem Cell. 2019. PMID: 30853558 Free article.
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, Nagano H, Hatano E, Izumi N, Kaneko S, Kudo M, Iijima H, Genda T, Tateishi R, Torimura T, Igaki H, Kobayashi S, Sakurai H, Murakami T, Watadani T, Matsuyama Y. Kokudo N, et al. Among authors: kaneko s. Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6. Hepatol Res. 2019. PMID: 31336394
In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC.
Ueda T, Kaneko S. Ueda T, et al. Among authors: kaneko s. Methods Mol Biol. 2019;2048:85-91. doi: 10.1007/978-1-4939-9728-2_10. Methods Mol Biol. 2019. PMID: 31396933
CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S, Morioka MS, Kawaji H, Shiozawa K, Machitani M, Abe T, Yamada S, Kaneko MK, Kato Y, Furuta Y, Kondo T, Shirouzu M, Hayashizaki Y, Kaneko S, Masutomi K. Yasukawa M, et al. Among authors: kaneko s. Nat Commun. 2020 Mar 25;11(1):1557. doi: 10.1038/s41467-020-15289-7. Nat Commun. 2020. PMID: 32214089 Free PMC article.
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Hosokawa M, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H. Imamura K, et al. Among authors: kaneko s. Sci Transl Med. 2017 May 24;9(391):eaaf3962. doi: 10.1126/scitranslmed.aaf3962. Sci Transl Med. 2017. PMID: 28539470 Free article.
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M, Okusaka T, Kobayashi M, Kumada H, Kaneko S, Pracht M, Mamontov K, Meyer T, Kubota T, Dutcus CE, Saito K, Siegel AB, Dubrovsky L, Mody K, Llovet JM. Finn RS, et al. Among authors: kaneko s. J Clin Oncol. 2020 Sep 10;38(26):2960-2970. doi: 10.1200/JCO.20.00808. Epub 2020 Jul 27. J Clin Oncol. 2020. PMID: 32716739
Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine.
Hamamoto R, Komatsu M, Takasawa K, Asada K, Kaneko S. Hamamoto R, et al. Among authors: kaneko s. Biomolecules. 2019 Dec 30;10(1):62. doi: 10.3390/biom10010062. Biomolecules. 2019. PMID: 31905969 Free PMC article. Review.
3,026 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback